High-dose-rate monotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for High-dose-rate monotherapy, covering 2024-02-21 to 2024-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer [Phase 2]